Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18-12

Ji Hyun Park; Sang Hoon Chun; Yun-Gyoo Lee; Hyun Chang; Keun-Wook Lee; Hye Ryun Kim; Seong Hoon Shin; Ho Jung An; Kyoung Eun Lee; In Gyu Hwang; Myung-Ju Ahn; Sung-Bae Kim; Bhumsuk Keam

doi:10.1007/s00432-020-03342-3

Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18-12

J Cancer Res Clin Oncol. 2020 Dec;146(12):3371. doi: 10.1007/s00432-020-03342-3.

Authors

Ji Hyun Park¹, Sang Hoon Chun², Yun-Gyoo Lee³, Hyun Chang⁴, Keun-Wook Lee⁵, Hye Ryun Kim⁶, Seong Hoon Shin⁷, Ho Jung An⁸, Kyoung Eun Lee⁹, In Gyu Hwang¹⁰, Myung-Ju Ahn¹¹, Sung-Bae Kim¹², Bhumsuk Keam¹³

Affiliations

¹ Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea.
² Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
³ Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
⁴ Department of Internal Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Republic of Korea.
⁵ Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
⁶ Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
⁷ Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Republic of Korea.
⁸ Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Republic of Korea.
⁹ Department of Hematology and Oncology, Ewha Woman's University Hospital, Seoul, Republic of Korea.
¹⁰ Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
¹¹ Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
¹² Department of Internal Medicine, Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. sbkim3@amc.seoul.kr.
¹³ Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. bhumsuk@snu.ac.kr.

PMID: 32852636
DOI: 10.1007/s00432-020-03342-3

Abstract

In the original article published, the first name of the author is incorrect. The correct author name is Ji Hyun Park.

Publication types

Published Erratum